BDNF and neoplasm: At the tissue scale, tumor–nerve crosstalk contributes additional neurotrophic input; studies across solid tumors document neural remodeling and nerve−derived cues that shape angiogenesis, stromal activation, and immune effector function (45–47), providing a framework for how neurotrophins and adrenergic/peptidergic signals converge on antitumor immunity.